Denali Ventures

Venture Capital Active Israel
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$26.0M
total disclosed, rounds participated
Stages

Portfolio · 1

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Denali Ventures' primary sector focus?
Denali Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.
Can you name a notable exit for Denali Ventures?
Denali Ventures had a notable exit with Gamida Cell, which went public on NASDAQ in October 2018 with a valuation of $210M.
What is the most recent investment activity for Denali Ventures?
Denali Ventures' most recent recorded investment activity was in May 2012.
What is Denali Ventures' typical investment stage?
Denali Ventures has participated in D Round and E Round funding stages.
Which company is a key part of Denali Ventures' portfolio?
Gamida Cell, a company focused on Cellular and Immune Therapies, is a key part of Denali Ventures' portfolio.
What is the total amount raised by Gamida Cell, a Denali Ventures portfolio company?
Gamida Cell, a Denali Ventures portfolio company, has raised $416.22M.